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Abstract
Background: Systemic inflammation induces neuroimmune activation, ultimately leading to sickness (e.g., fever,
anorexia, motor impairments, exploratory deficits, and social withdrawal). In this study, we evaluated the role of
protein kinase R (PKR), a serine-threonine kinase that can control systemic inflammation, on neuroimmune
responses and sickness.
Methods: Wild-type (WT) PKR+/+ mice and PKR−/− mice were subcutaneously injected with live Escherichia coli
(E. coli) or vehicle. Food consumption, rotarod test performance, burrowing, open field activity, object investigation,
and social interaction were monitored. Plasma TNF-α and corticosterone were measured by ELISA. The percentage of
neutrophils in blood was deduced from blood smears. Inflammatory gene expression (IL-1β, TNF-α, IL-6, cyclooxygenase
(COX)-2, iNOS) in the liver and the brain (hypothalamus and hippocampus) were quantified by real-time PCR. Blood
and lavage fluid (injection site) were collected for microbiological plate count and for real-time PCR of bacterial 16S
ribosomal DNA (rDNA). Corticotrophin-releasing hormone (CRH) expression in the hypothalamus was also determined
by real-time PCR.
Results: Deficiency of PKR diminished peripheral inflammatory responses following E. coli challenge. However, while
the core components of sickness (anorexia and motor impairments) were similar between both strains of mice, the
behavioral components of sickness (reduced burrowing, exploratory activity deficits, and social withdrawal) were only
observable in PKR−/− mice but not in WT mice. Such alteration of behavioral components was unlikely to be caused
by exaggerated neuroimmune activation, by an impaired host defense to the infection, or due to a dysregulated
corticosterone response, because both strains of mice displayed similar neuroimmune responses, bacterial titers,
and plasma corticosterone profiles throughout the course of infection. Nevertheless, the induction of hypothalamic
corticotrophin-releasing hormone (CRH) by E. coli was delayed in PKR−/− mice relative to WT mice, suggesting that
PKR deficiency may postpone the CRH response during systemic inflammation.
Conclusions: Taken together, our findings show that (1) loss of PKR could alter E. coli-induced sickness behaviors
and (2) this was unlikely to be due to exacerbated neuroimmune activation, (3) elevated bacterial load, or (4)
dysregulation in the corticosterone response. Further studies can address the role of PKR in the CRH response
together with its consequence on sickness.
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Background
Sickness refers to a set of physiological and behavioral re-
sponses (e.g., fever, anorexia, immobility, reduced explora-
tory activity, social withdrawal, anhedonia) to systemic
inflammation [1–3]. Collectively, these changes serve as
the body’s adaptive strategies to combat infections and
injuries [4]. However, increasing lines of evidence have
indicated that the same responses can become deleterious
if exacerbated [1, 5–7]. Therefore, it will be beneficial to
understand how sickness is regulated.
The regulation of sickness is a complex subject. Upon
an inflammatory insult, innate immune cells sense
pathogen-associated molecular patterns (PAMPs) and
alarmins that are respectively released from pathogens
and damaged tissues [8, 9], and respond by upregulat-
ing cytokines [10, 11], prostaglandins [12, 13], and
complement factors [14, 15]. These systemic inflammatory
mediators communicate to the brain via multiple humoral
and neural routes, causing neuroimmune activation and
sickness [16–20]. Accordingly, inflammation is import-
ant for sickness development, and a reduction of in-
flammation should help to suppress sickness. Indeed,
both peripheral [10, 17, 21, 22] and central [23–26]
administration of exogenous inflammatory molecules
acutely triggers sickness. On the contrary, pharmaco-
logical inhibition of the synthesis [27–30] or the ac-
tions [31–34] of endogenous inflammatory mediators
can decrease sickness following immune challenge by
lipopolysaccharide (LPS).
Protein kinase R (PKR) is a ubiquitously expressed
serine-threonine kinase that was originally discovered as
an antiviral defense mediator [35, 36]. Upon viral infec-
tion, PKR binds to double-stranded RNA (dsRNA) from
viruses through its N-terminal dsRNA-binding domain,
resulting in PKR dimerization and autophosphorylation
and activation of the C-terminal kinase domain [37–39].
Activated PKR can inhibit viral infection by phosphoryl-
ating eukaryotic initiation factor 2 (eIF2α) to decrease
protein translation [40–42] and/or by inducing apoptosis
of infected cells [43, 44].
Apart from its traditional antiviral roles, our group
is more interested in the role of PKR in regulating
inflammation. For instance, PKR can be activated
during inflammation, as illustrated by an increase of
PKR phosphorylation in macrophages following CD40
ligation [45] and when stimulated by toll-like receptor
(TLR) ligands [46]. Furthermore, PKR shows crosstalk
with inflammatory pathways such as c-Jun-N-terminal
kinase (JNK) [46, 47], mitogen-activated protein kinase
(MAPK) [48], nuclear factor-kappa B (NF-κB) [47, 49], sig-
nal transducers and activators of transcription 1 (STAT1)
[50], interferon-regulatory factor-1 (IRF-1) [49], and inflam-
masome [51]. It can affect cytokine production and release
from cultured fibroblasts [47, 48], macrophages [46, 51],
and mixed glia/neuron co-cultures [52]. On the other hand,
genetic deletion of PKR in mice attenuates plasma IL-6 and
IL-12 increases triggered by LPS [48]. Until recently, PKR
has also been shown to control neuroinflammatory
changes in animal models of viral encephalitis [53]
and excitotoxic injury [54].
Since systemic inflammation triggers neuroimmune ac-
tivation and sickness, and that PKR modulates inflamma-
tion, the purpose of this study is to investigate whether
PKR can affect neuroimmune responses and sickness
induced by systemic inflammatory challenge. Wild-type
(WT) and PKR−/− mice were subcutaneously injected
with live Escherichia coli (E. coli) or vehicle. As predicted,
deficiency of PKR diminished peripheral inflammatory re-
sponses to E. coli. However, to our surprise, the loss of
PKR did not decrease sickness. Instead, PKR−/− mice dis-
played several behavioral components of sickness (reduced
burrowing, exploratory deficits, and social withdrawal)
that were not observed in WT mice. Moreover, these
altered sickness behaviors were unlikely to be caused by
exaggerated neuroimmune activation or increased bacter-
ial load, because both strains of mice showed similar neu-
roimmune responses and bacterial titers throughout the
course of infection. As systemic inflammation can activate
the hypothalamic-pituitary-adrenal (HPA) axis which can
potentially regulate sickness [55–60], we further asked
whether PKR modulates HPA axis activation following E.
coli challenge. Both strains of mice exhibited similar
changes in plasma corticosterone levels post-infection.
Nevertheless, PKR−/− mice displayed a delayed induc-
tion of corticotrophin-releasing hormone (CRH) in the
hypothalamus as compared to WT mice, suggesting
that the loss of PKR may postpone the CRH response
to systemic inflammation. Taken together, our findings
show that (1) deficiency of PKR could alter E. coli-induced
sickness behaviors and (2) this was not because of exacer-
bated neuroimmune activation, (3) increased bacterial
load, or (4) dysregulation of the corticosterone response.
However, knockout of PKR could delay the CRH re-




All animal procedures were approved by the Committee
on the Use of Live Animals in Teaching and Research
(CULATR) of the University of Hong Kong (HKU).
Wild-type C57BL/6 mice were purchased from the
Laboratory Animal Unit (LAU) of the LKS Faculty of
Medicine in HKU. Breeders of PKR−/− mice having tar-
geted disruption in exons 2 and 3 of the PKR gene [61]
were generously given by Prof. Bryan Williams. These
mice were maintained on a C57BL/6 background prior
to their arrival at our laboratory. Genome-wide single
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nucleotide polymorphism (SNP) scanning (The Jackson
Laboratory, Bar Harbor, USA) also verified that 99 % of
the genetic makeup of PKR−/− mice is of C57BL/6. All
mice were bred under a specific pathogen-free (SPF) en-
vironment maintained at 24–26 °C and under a 12:12 h
light:dark cycle (lights on 08:00–20:00) in LAU. Mice
were used when they reached maturity at 3 months old,
and only females were included to limit fighting. Individ-
ual variability in the estrous cycle was not controlled in
animal husbandry. Mice were group caged (4–5 mice
per cage) and provided with food and water ad libitum.
Bacterial culture
E. coli (ATCC 15746, American Type Collection, Mana-
ssa, VA) was cultured as previously described [62–64].
Briefly, after reconstituting in 35-ml brain heart infusion
(BHI) broth (BD Diagnostic Systems, NJ, USA), the cul-
ture was incubated overnight at 37 °C, 5 % CO2. On the
next day, it was supplemented with glycerol (10 % v/v),
aliquoted, frozen, and stored at −80 °C. These aliquots
served as glycerol stocks. Typically, on the day before in-
jection, 0.5 ml of glycerol stock was used to inoculate
35 ml BHI and grown overnight as described above. The
bacterial concentration was quantified by measuring its
absorbance at 595 nm and extrapolating from a previ-
ously determined standard curve. The bacteria were cen-
trifuged at 4000×g for 30 min, the supernatant was
removed, and the bacterial pellet was re-suspended in
sterile phosphate buffered saline (PBS).
Experimental paradigm
Four days before the injection, mice were transferred
from LAU to an isolated behavioral testing room that
was maintained at 24–26 °C and under a 10:14 h light:-
dark cycle (lights on 09:00–19:00). A small area of hair,
i.e., 1 × 1 cm, was shaved from the back (i.e., just caudal
to the ears) of each mouse to facilitate inspection of
local inflammation. Mice were then singly caged, and
allowed to habituate for 4 days in the behavioral room.
On the day after the habituation period, mice were ei-
ther injected with 0.5 ml sterile PBS (vehicle) or 8 × 108
colony-forming unit (CFU) E. coli. This dose was chosen
based on our preliminary observations that it can pro-
duce obvious signs of sickness (e.g., anorexia, decreased
activity) in mice for several days without causing severe
mortality (mortality rate was below 1 %) or extreme
weight loss (weight loss was less than 10 % of the starting
body weight). All injections took place at 11:00–12:00, and
mice were monitored for the next 120 h.
Food consumption
The amount of food given to each mouse (placed on the
cage top) was pre-weighed, and the amount remaining
24 h later was weighed again. The amount of food
consumed in a day was calculated by the difference be-
tween the two masses. Any food material that was not
consumed in the previous day was discarded to minimize
spill over to the next day.
Rotarod test
The rotarod test was performed as previously described
but with some minor modifications [65]. Briefly, the ap-
paratus consisted of a horizontal rotatable rod (10 cm
long, 6 cm in diameter) surrounded by vertical boards to
prevent animal escape. A padding material (a stack of
plastic bags) was placed at the bottom of the setup to
minimize animal injury when the animal falls from the
rod. A mouse was placed with its front paws just touch-
ing the rotating rod and immediately released. The speed
of rotation was gradually accelerated, and the time of
which the mouse stayed on the rod before falling was re-
corded. Mice staying for more than 3 min were counted
as staying for 3 min. Each mouse was given three trials
each time, and the average of the three readings was
used for data analysis. Mice were trained for the rotarod
test on two different days of the habituation period to
acclimatize them to the procedure, and tested at 24 and
96 h after the injection.
Burrowing
Burrowing is a rodent-specific behavior, and this behav-
ior has been used to study sickness [11, 27, 28]. This
setup consisted of an opaque and hollow plastic tube
(6 × 6 × 15 cm), sealed at one end and with the other
end being tilted at an angle such that it could stand
1 cm above the cage floor. It was filled with a bedding
material (~60 g), and together they were pre-weighed.
The tube was then introduced into the cage, and the
mouse was allowed to burrow while the experimenter
remained outside the room. One hour after testing, the
tube and its contents were weighed again, and the
amount of bedding material burrowed was calculated by
the difference between the two readings. Mice were
trained to burrow during the habituation period to limit
inter-individual variation in baseline burrowing activity
and were tested every 24 h after the injection.
Open field test
The open field test [66] was conducted in a 40 cm
(L) × 30 cm (W) × 40 cm (H) white plastic arena, with
a floor that was gridded into 12 equal 10 × 10 cm
squares. A mouse facing at a corner of the arena, and
having its front paws just touching the arena floor,
was quickly released. It was allowed to explore the
open field for 3 min, during which its behavior was
videotaped. Testing was performed under quiet and
dim lighting, and the experimenter remained outside
the behavioral room throughout the test. The number
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of lines crossed by the mouse in this novel environ-
ment was determined from the video, and validated
by an independent experimenter. Testing was per-
formed at 120 h post-injection.
Object investigation test
Immediately after the open field test, the mouse was tem-
porarily returned to its home cage, and two identical trans-
parent plastic cages, i.e., 8 cm (L) × 6 cm (W) × 12 cm (H)
and having holes on its sides, were placed one on each side
(6 cm side) of the arena. The mouse was introduced back
into the arena, with its head facing the wall of one of the
8-cm sides and its front paws just touching the floor, and
immediately released. It was allowed to explore the two
transparent cages for 3 min, during which it was video-
taped. The experimenter remained outside the room. The
amount of time the mouse spent investigating both novel
cages was determined from the videotape and validated by
another independent experimenter. A mouse was regarded
as interacting with the cage if it (1) physically contacted
with the cage or if (2) its nose was 2 cm near the cage.
Any accidental bumping of the mouse to the cage by its
limbs or its body was not regarded as interaction. One E.
coli-injected PKR−/− mice jumped onto a cage and
remained there for the whole period, and hence it was not
included in the data analysis.
Social interaction test
The social interaction test was conducted similarly as re-
ported but with some modifications [67]. Immediately
following the object investigation test, the mouse was
returned back to its home cage, and a novel female
C57BL/6 mouse (~3 weeks old) was put into one of the
two empty cages. The subject mouse was introduced
back into the arena in the same way as above. The be-
havior of the mouse was recorded for the next 3 min.
The time that the subject mouse spent interacting with
the empty cage and the time that it spent interacting
with the social cage were both deduced from the video
and validated by an independent experimenter. Five
mice jumped onto a cage and were rejected for data ana-
lysis. After the test, the entire apparatus was washed
with running tap water, wiped with towel, and allowed
to dry before testing the next mouse. The same novel
mouse was used across all subject mice.
Total RNA extraction, genomic DNA digestion, and
reverse transcription
Mice were sacrificed with an overdose of sodium pento-
barbital (100 mg/kg). The liver and brain were quickly
collected, and the hypothalamus (within Bregma 0.86
to −2.7 mm) and hippocampus (within Bregma −0.82
to −3.8 mm) were isolated on ice. Total RNA was ex-
tracted using TRI Reagent® RT (Molecular Research
Centre Inc, Cincinnati, USA) according to the manu-
facturer’s protocol. The RNA concentrations in the
samples were quantified by NanoDrop 2000c (Thermo
Scientific, Wilmington, USA). All RNA samples had
A260/A280 ratios of 1.8–2.0 and showed distinct
bands for the 28S and 18S rRNA subunits on a gel. To
remove any contaminating genomic DNA, 4 μg total
RNA from each sample was treated with DNA-free™
DNA Removal Kit (Life Technologies, Carlsbad, USA)
in a 22-μl reaction volume, and 8 μl of the reaction
(~1.45 μg total RNA) was taken for reverse transcrip-
tion by SuperScript™ III First-Strand Synthesis system
(Life Technologies, Carlsbad, USA). cDNA samples
were 10× diluted in DEPC-treated water.
Real-time PCR
Two microliters of diluted cDNA was amplified in tripli-
cate with SYBR Premix Ex Taq™ II kit, Perfect Real Time
(Takara Bio Inc, Shiga, Japan) and employing the MyiQ™2
two-color Real-Time PCR detection System (Bio-Rad,
Hercules, USA). The general PCR protocol was as follows:
95 °C for 120 s, 95 °C for 15 s, annealing temperature
(refer to Table 1) for 30 s, and 72 °C for 10–30 s (see
Table 1) for 45 cycles. The specificity of PCR was con-
firmed by ensuring that there was only one peak in the
melting curve analysis and only one band matching to the
size the PCR product on a gel. All PCR amplification effi-
ciencies were 90–110 %. The expression level of each
mouse gene was extrapolated from the standard curve
and normalized to the expression level of a house-
keeping gene glyceraldehyde 3-phosphate dehydrogen-
ase (GAPDH). Our preliminary results indicated that
GAPDH expression was unaffected by genotype or by E.
coli in the brain and liver. Results for the mouse genes were
reported as relative mRNA expression. Results of 16S ribo-
somal DNA (rDNA) do not require the normalization step
and were reported as fold of the WT PBS group.
Assessment of blood neutrophil percentage
An increase of blood neutrophil granulocytes can serve
as an indicator of systemic inflammation [68]. To assess
this, whole blood was collected from mice by making a
tail nick. Twenty microliters of blood was spotted onto a
glass slide to produce a blood smear, and three blood
smears were prepared per mouse. Slides were fixed in
methanol for 30 s and allowed to dry under room
temperature. They were stained with 5 % Giemsa stain,
pH 6.8 (Medical Chemical Corporation, Torrance, USA)
for 20 min and briefly washed in deionized water. Next,
they were dehydrated in a graded series of ethanol,
cleared in toluene, mounted with Permount (Sigma Al-
drich, St. Louis, USA), and coverslipped. Slides were
viewed under a 40× objective of a Zeiss Axiophot micro-
scope (Carl Zeiss, Thornwood, USA) connected to a
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SPOT RT3™ camera (SPOT Imaging Solutions, Sterling
Heights, USA). Ten bright view images were captured at
the “zone of morphology” in each slide, and three slides
per mouse. The numbers of neutrophils and leukocytes
were manually counted. Neutrophil % was calculated by
Neutrophil % = (Average no. of neutrophils/Average no.
of leukocytes) × 100 %.
Determination of bacterial titer
Bacterial titers at the injected site and in blood were quan-
tified every 24 h by microbiological plate count and by
real-time PCR for bacterial 16S rDNA. Briefly, lavage fluid
was collected by subcutaneously injecting 1 ml of sterile
phosphate buffered saline (PBS) at the injection site and
immediately withdrawing ~200 μl using another pair of
sterile needle and syringe. Blood was obtained by making
a tail nick as described above and supplemented with ster-
ile disodium EDTA (3.6 mM) for anti-coagulation. For the
plate count method, blood and lavage samples were seri-
ally diluted with sterile PBS. The diluted samples were
spread onto pre-warmed lysogeny broth (LB) agar plates
(BD Diagnostic Systems, NJ, USA) and incubated at 37 °C.
After 24 h, the number of colonies was counted by two in-
dependent observers, and the corresponding bacterial titer
in the undiluted sample was calculated. The 16S rDNA
method was performed as previously described but with a
few minor modifications [69]. In brief, 20 μl of lavage fluid
and 50 μl of anti-coagulated blood were respectively
treated with 25 and 65 U of mutanolysin (Sigma Aldrich,
St. Louis, USA) at 37 °C for 30 min. Genomic DNA was
purified from the mutanolysin-treated samples using the
QIAamp DNA Mini kit (Qiagen Inc., Valencia, CA) based
on the manufacturer’s protocol and eluted in 100 μl of
double distilled water. Two microliters of the elution was
used for real-time PCR for 16S rDNA as described before.
TNF-α and corticosterone ELISA
Mice were sacrificed with an overdose of sodium pento-
barbital (100 mg/kg) at 4 h (16:00) and 48 h (12:00).
Heparinized blood was collected by cardiac puncture,
centrifuged, and the plasma was removed and stored at
−80 °C until analysis. TNF-α and corticosterone levels
were determined using Mouse TNF-alpha DuoSet ELISA
Kit (R&D systems Inc, Minneapolis, Canada) and Cor-
ticosterone EIA Kit (Cayman Chemical Company, Ann
Arbor, USA), respectively, according to the manufac-
turers’ instructions. For the ELISA of corticosterone,
plasma samples were first 200× diluted in assay buffer.
The detection limit of the TNF-α ELISA assay was
31 pg/ml, and that of the corticosterone ELISA assay was
30 pg/ml (i.e., 6 ng/ml in the undiluted sample).
Data and statistical analysis
Statistical analysis was conducted by SigmaStat® 3.0
(Jandel Scientific, San Rafael, USA). Data for food con-
sumption, burrowing, and the rotarod test were analyzed
by two-way repeated measures of analysis of variance
(ANOVA) with genotype (WT E. coli v.s. PKR−/− E. coli)
and time as the main factors. If a significant interaction
effect could be detected, Bonferroni post hoc comparison
Table 1 The PCR conditions for IL-1β, TNF-α, IL-6, COX-2, iNOS, CRH, GAPDH, and 16S rDNA








IL-1β (118130747) F: 5′-CCTCCTTGCCTCTGATGG-3′ 0.4 60 10 99
R: 5′-AGTGCTGCCTAATGTCCC-3′
TNF-α (518831586) F: 5′-CCCCAGTCTGTATCCTTCT-3′ 0.4 59 30 106
R: 5′-ACTGTCCCAGCATCTTGT-3′
IL-6 (13624310) F: 5′-GGCAATTCTGATTGTATG-3′ 0.4 56 30 208
R: 5′-CTCTGGCTTTGTCTTTCT-3′
COX-2 (118130137) F: 5′-GATGACTGCCCAACTCCC-3′ 0.25 60 10 191
R: 5′-AACCCAGGTCCTCGCTTA-3′
iNOS (146134510) F: 5′-AAACGCTTCACTTCCAATG-3′ 0.4 61 30 296
R: 5′-CAATCCACAACTCGCTCC-3′
CRH (292781723) F: 5′-GTGCGGGCTCACCTACCAA-3′ 0.4 57 10 107
R: 5′-AGGCAGGCAGGACGACAGA-3′
GAPDH (576080554) F: 5′-ATTCAACGGCACAGTCAA-3′ 0.4 56 10 77
R: 5′-CTCGCTCCTGGAAGATGG-3′
16S rDNA (J01859.1) F: 5′-GCAAGCGGACCTCATAAA-3′ 0.25 54 20 100
R: 5′-ATTCACCGTGGCATTCTG-3′
The real-time PCR conditions for IL-1β, TNF-α, IL-6, COX-2, iNOS, CRH, GAPDH, and 16S rDNA. Accession numbers from the Genebank are shown in brackets.
COX-2 cyclooxygenase-2, CRH corticotrophin-releasing hormone, iNOS inducible nitric oxide synthase, TNF-α tumor necrosis factor-α, IL interleukin
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was performed. Additionally, selected time points for food
consumption and the rotarod test were analyzed by one-
way ANOVA followed by Student-Newman-Keuls post
hoc comparison. The open field test, object investigation
test, and social interaction test were replicated in two in-
dependent batches of experiments (including all four
treatment groups in each batch). For the open field and
object investigation tests, data were first expressed as fold
of the WT PBS group of the same batch of experiment be-
fore both batches were combined for data analysis. They
were then analyzed by one-way ANOVA followed by
Student-Newman-Keuls post hoc comparison. For the so-
cial interaction test, data from the same experiment were
expressed as fold of interaction with the social cage of the
WT PBS group, and data from both batches were pooled.
Interaction effect between experimental group (WT or
PKR−/− mice injected with PBS or E. coli) and cage (social
v.s. empty) was analyzed by two-way ANOVA, followed
by, if significant, Bonferroni post hoc comparison.
Data including all four experimental groups (WT PBS,
WT E. coli, PKR−/− PBS, PKR−/− E. coli) for real-time
PCR, neutrophil %, and ELISA were analyzed by one-
way ANOVA followed by Student-Newman-Keuls post
hoc comparison. Additionally, two-tailed t tests were
performed to analyze for potential differences in
baseline corticosteroid levels across time (4 h WT
PBS v.s. 48 h WT PBS; 4 h PKR−/− PBS v.s. 48 h
PKR−/− PBS). Data of bacterial plate count and 16S
rDNA were positively skewed and were thus log trans-
formed [70]. Transformed data were analyzed by two-
way ANOVA with genotype (WT E. coli v.s. PKR−/−
E. coli) and time as the main factors. All values were
represented as mean ± standard error from the mean
(SEM), and results were considered significantly dif-
ferent if p < 0.05.
Results
PKR−/− mice displayed altered E. coli-induced sickness
behaviors
Systemic inflammation induces both core (e.g., fever, an-
orexia, motor impairments) and behavioral (e.g., social
withdrawal, reduced exploration, anhedonia, cognitive
deficits) components of sickness [5, 19, 71]. As PKR has
been known to regulate inflammation [36, 72], we evalu-
ated whether loss of PKR would also affect these two
components of sickness.
Deficiency of PKR did not affect the core components
of sickness. For example, WT and PKR−/− mice displayed
similar reductions in food consumption after E. coli, and
these changes were gradually restored by day 3 (Fig. 1a).
Two-way repeated measures ANOVA of the E. coli-
treated groups did not indicate any interaction effect
(F = 0.749, df 4, 60, p = 0.563) between genotype (WT
E. coli or PKR−/− E. coli) and the time post-injection,
implying that the genotype had no effect on the anorexic
responses across time. As further supportive evidence,
one-way ANOVA followed by Student-Newman-Keuls
post hoc comparison showed that E. coli was able to de-
crease (p < 0.001) food consumption in WT mice (WT
PBS v.s. WT E. coli) and PKR−/− mice (PKR−/− PBS
v.s. PKR−/− E. coli) on day 1 and day 2, but no differ-
ence (p > 0.05) could be found between the E. coli-chal-
lenged groups on both days. Likewise, both strains of
mice showed similar motor impairments in the rotarod
test following E. coli (Fig. 1b). Two-way repeated mea-
sures ANOVA of the E. coli-challenged groups did
not show any interaction between genotype and time
(F = 0.0753, df 2, 27, p = 0.0928). Moreover, one-way
ANOVA with Student-Newman-Keuls post hoc test
indicated that E. coli decreased motor performance
(p < 0.05) in WT and PKR−/− mice at 24 h, but
again there was no difference (p = 0.822) between the
E. coli-treated groups.
Although the core components of sickness were similar
between WTand PKR−/− mice, the behavioral components
of sickness were altered in PKR−/− relative to WT mice. As
shown in Fig. 1c, E. coli reduced burrowing in PKR−/−
mice but not in WT mice. Two-way repeated measures
ANOVA of the E. coli-challenged groups indicated a main
effect of genotype (F = 9.002, df 1, 75, p = 0.009) and an
interaction between genotype and time (F = 2.796, df 5, 75,
p = 0.023), suggesting that the effect of genotype on the
burrowing deficits depended on the time post-injection.
Bonferroni post hoc comparison showed that the PKR−/−
E. coli group had significantly lesser burrowing activity
than the WT E. coli group at 7 h (p < 0.001) and 24 h
(p = 0.001). In addition, at 120 h post-injection, a time
when the core components of sickness had disap-
peared in both strains of mice, PKR−/− mice still dis-
played reduced exploratory activities in the open field
test (Fig. 1d) and object investigation test (Fig. 1e).
One-way ANOVA followed by Student-Newman-Keuls
post hoc test showed that E coli significantly decreased
(p < 0.05) the exploratory activities of PKR−/− mice
(PKR−/− PBS v.s. PKR−/− E. coli) in both tasks and
that the PKR−/− E. coli group also explored signifi-
cantly lesser as compared to the WT E. coli group. Fi-
nally, we found that E. coli triggered social withdrawal
in PKR−/− mice but not in WT mice at 120 h (Fig. 1f ).
Two-way ANOVA with cage (social v.s. empty) and
experimental grouping (WT PBS/WT E. coli/PKR−/−
PBS/PKR−/− E. coli) as the main factors indicated a
main effect of cage (F = 60.489, df 1, 96, p < 0.001) and
an interaction between cage and experimental group
(F = 3.044, df 3, 96, p < 0.033). Hence, the effect of the
social cage depended on the experimental group. Bon-
ferroni post hoc comparison found significant differ-
ences (p < 0.001) between social v.s. empty cages in
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the WT PBS, WT E. coli, and PKR−/− PBS groups, but
not in the PKR−/− E. coli group (p = 0.099). The inves-
tigation of the social cage in the PKR−/− E. coli group
was also significantly lesser than that of the other
three experimental groups (p < 0.05).
PKR−/− mice displayed reduced peripheral inflammatory
responses to E. coli
A previous study has demonstrated that genetic defi-
ciency of PKR can attenuate plasma cytokine increases













Fig. 1 Effects of PKR deficiency on E. coli-induced sickness. WT and PKR−/− mice were subcutaneously challenged by E. coli or PBS, and sickness
responses were monitored for the next 120 h. Infection of E. coli led to similar decreases in food consumption (a) and rotarod test performance
(b) in WT and PKR−/− mice. *p < 0.05, ***p < 0.001, WT E. coli versus WT PBS; +p < 0.05, +++p < 0.001, PKR E. coli versus PKR PBS; n = 8 per group.
However, E. coli suppressed burrowing in PKR−/− mice but not in WT mice (c). **p < 0.01, ***p < 0.001, PKR−/− E. coli versus PKR−/− PBS, n = 8
per group. Furthermore, at 120 h post-injection, E. coli downregulated open field (d) and object investigation (e) activities in PKR−/− mice but
not in WT mice. *p < 0.05, ***p < 0.001; n = 13–16 per group. Likewise, E. coli decreased social interaction in PKR−/− mice but not in WT mice at
120 h (f). ***p < 0.001, empty cage versus social cage of the same experimental group; #p < 0.05, ##p < 0.01, ###p < 0.001 versus interaction with
the social cage of the PKR−/− E. coli group; n = 12–15 per group
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be reasonable to postulate that loss of PKR should simi-
larly reduce peripheral inflammatory changes after a
subcutaneous injection of E. coli. However, since only
PKR−/− mice developed observable behavioral compo-
nents of sickness, we first questioned whether genetic
deletion of PKR would unexpectedly promote peripheral
inflammation in response to an E. coli infection.
Consistent with the earlier study [48], PKR−/− mice
showed diminished peripheral inflammatory responses to
E. coli. Genetic deletion of PKR suppressed inflammatory
gene induction (IL-1β, TNF-α, IL-6, cyclooxygenase
(COX)-2, iNOS) in the liver (Fig. 2), where the highest
density of tissue macrophages, i.e., Kupffer cells, reside in
the body [73]. Particularly at 4 h, post hoc Student-
Newman-Keuls test after one-way ANOVA showed that
E. coli upregulated (p < 0.01) all five inflammatory genes in
both strains of mice, but the induction in PKR−/− mice
was significantly lower (p < 0.05) than that of WT mice.
At 48 h, the levels of IL-1β, TNF-α, and iNOS still
remained elevated (p < 0.01) by E. coli, but there was no
















4 h                        48 h                       120 h
Fig. 2 Relative mRNA expression profiles of IL-1β, TNF-α, IL-6, COX-2, and iNOS in the liver. Loss of PKR inhibited inflammatory gene expression in
the liver triggered by E. coli, particularly at 4 h. n = 7–8 per group at 4 h, n = 6–8 per group at 48 h, and n = 9–11 per group at 120 h. ND not
detectable; *p < 0.05, **p < 0.01, ***p < 0.001
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significant difference (p > 0.05) between the E. coli-treated
groups. At 120 h, even smaller increases (p < 0.05) of IL-
1β (WT and PKR−/− mice) and iNOS (WT mice only)
were detected, and the expression of these genes were sig-
nificantly lower (p < 0.05) in the PKR−/− E. coli group
than in the WT E. coli group. In line with these findings,
deficiency of PKR led to a lesser increase of plasma TNF-α
at 4 h after E. coli challenge (Fig. 3a). In the PBS-injected
groups, plasma TNF-α levels were below the detection
limit (<31 pg/ml) of the ELISA assay. One-way ANOVA
followed by Student-Newman-Keuls post hoc test indi-
cated that E. coli elevated plasma TNF-α in WT mice
(WT PBS v.s. WT E. coli; p < 0.001) and PKR−/− mice
(PKR−/− PBS v.s. PKR−/− E. coli; p < 0.001) and that the
PKR−/− E. coli group had a lower level of TNF-α than the
WT E. coli group (WT E. coli v.s. PKR−/− E. coli; 152 ± 24
v.s. 88 ± 17 pg/ml; p = 0.003). Finally, an elevation of neu-
trophil granulocytes in blood can serve as an index of sys-
temic inflammation [68]. We found that deficiency of PKR
in mice triggered a smaller increment of neutrophil % at
120 h post-injection (Fig. 3b). One-way ANOVA followed
by Student-Newman-Keuls post hoc comparison showed
that E. coli upregulated neutrophil % in both WT mice
(WT PBS v.s. WT E. coli; 18.5 ± 2.1 v.s. 46.7 ± 3.1 %;
p < 0.001) and PKR−/− mice (PKR−/− PBS v.s. PKR−/− E.
coli; 21.2 ± 2.7 v.s. 38.1 ± 2.2 %; p < 0.001), and also a lower
neutrophil % was seen in the PKR−/− E. coli group than
in the WT E. coli group (p = 0.028).
Neuroimmune responses in WT and PKR−/− mice were
similar
Since peripheral inflammatory changes were suppressed
in PKR−/− mice, we asked whether neuroimmune re-
sponses would also be dampened in PKR−/− mice.
Therefore, we assessed inflammatory gene expression in
the hypothalamus and hippocampus after E. coli chal-
lenge in WT and PKR−/− mice. These two brain regions
were selected for analysis because of their high expres-
sion for cytokine receptors in the brain [74–76] and that
they are important in the control of the sickness [2]. To
our surprise, we found that both strains of mice dis-
played mostly similar increases of inflammatory genes at
both brain regions.
At 4 h in the hypothalamus (Fig. 4), E. coli significantly
upregulated mRNA expression for IL-1β, TNF-α, IL-6,
and COX-2 in WT and PKR−/− mice (p < 0.05, one-way
ANOVA followed by Student-Newman-Keuls post hoc
test), but no significant difference could be detected
(p > 0.05) between the E. coli-challenged groups for all
four genes. On the other hand, E. coli led to a small
drop (~30 %, p < 0.05) in iNOS mRNA expression in
PKR−/− mice (PKR−/− PBS v.s. PKR−/− E. coli), and
the PKR−/− E. coli group also showed significantly
lesser expression of iNOS (p < 0.05) than the WT E.
coli group. At 48 h, E. coli was still able to elevate IL-
1β, TNF-α, and COX-2 expression (p < 0.01) in both
genotypes of mice, and it also increased iNOS expres-
sion (p < 0.01) in WT mice. Among these genes, the
PKR−/− E. coli group displayed significantly lower ex-
pression for TNF-α (p < 0.01) and iNOS (p < 0.05) than
the WT E. coli group. IL-6 mRNA was similarly re-
duced by E. coli in both strains of mice (p < 0.001),
and no significant difference was found between the E.
coli-treated groups. At 120 h, small increases of TNF-
α (both genotypes, p < 0.05) and IL-1β (WT mice only,
p < 0.05) could still be observed, but no significant dif-
ference (p > 0.05) could be found among the E. coli-
treated groups for both genes.
Similarly, at 4 h in the hippocampus (Fig. 5), E. coli up-
regulated the mRNA expression of IL-1β, TNF-α, IL-6, and
COX-2 (p < 0.05) in WT and PKR−/− mice, but no signifi-
cant difference (p > 0.05) was found between the E. coli-
challenged groups of the two strains of mice. Likewise, at
48 h, there were still small increases (i.e., less than onefold,
p < 0.05) in the mRNA expression of IL-1β and COX-2
(WT and PKR−/− mice), TNF-α (PKR−/− mice only), and
iNOS (WT mice only), but none of these inflammatory
genes displayed any significant difference (p > 0.05) between
the E. coli-treated groups. At the same time point, IL-6
expression was decreased in both genotypes by E. coli
(p < 0.001), but the E. coli-treated groups did not differ
in IL-6 expression. Finally, at 120 h, only a small in-
crease of TNF-α (~40 %, p < 0.01) was observed in
PKR−/− mice after E. coli, but this also did not reach
statistical difference (p = 0.11) when compared to the
WT E. coli group.
Bacterial titers were similar between WT and PKR−/− mice
Given that loss of PKR in mice reduced peripheral in-
flammatory responses but at the same time led to more
observable behavioral components of sickness, we ques-
tioned whether PKR deficiency had exaggerated bacter-
ial load. By performing standard microbiological plate
counts and real-time PCR for bacterial 16S rDNA, we
Fig. 3 Deficiency of PKR led to smaller increases of plasma TNF-α
and neutrophil %. Peripheral blood was collected at 4 h for TNF-α
ELISA (a) and at 120 h (b) for peripheral leukocyte count after the
injection of PBS or E. coli. n = 8–10 per group in a, and n = 13–16
per group in b. ND not detectable; *p < 0.05, **p < 0.01, ***p < 0.001
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found that the changes of bacterial titers were similar
between the two strains of mice at the injection site
(i.e., lavage fluid) and in blood throughout the course
of infection.
For the plate count method, we observed that lavage
fluid from the PBS-injected mice of both strains did not
produce any colonies, thus ruling out the possibility of
sample contamination during the procedure. However,
lavage fluid from the E. coli-injected mice gave rise to
numerous bacterial colonies (Fig. 6a). Two-way ANOVA
of the log transformed data indicated a main effect of
time (F = 4.206, df 4149, p = 0.003) on the level of
colony-forming units (CFU), but no interaction could be
detected between genotype (WT E. coli v.s. PKR−/− E.
coli) and time (F = 0.838, df 4, 149, p = 0.503). Hence, al-
though bacterial titers varied with time, genotype had no
effect on the change of bacterial titers across time.
Moreover, we did not recover any bacterial colonies
from the blood samples of the bacterial challenged mice
at any of the time points included, suggesting that the E.
















4 h                        48 h                       120 h
Fig. 4 Relative mRNA expression profiles of IL-1β, TNF-α, IL-6, COX-2, and iNOS in the hypothalamus. The loss of PKR had little effect on inflammatory
gene expression in the hypothalamus after E. coli challenge. n = 7–8 per group at 4 h, n = 6–8 per group at 48 h, and n = 9–11 per group at the 120 h
time point. *p < 0.05, **p < 0.01, ***p < 0.001
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coli infection did not spread into the blood circulation in
either genotype.
Consistent to the plate count results, the levels of
bacterial 16S rDNA in lavage fluid were also similar be-
tween WT and PKR−/− mice (Fig. 6b). Two-way
ANOVA of the log transformed data indicated a main
effect of time (F = 4.854, df 2, 75, p = 0.01), but there was
no interaction between time and genotype (F = 0.671, df 2,
75, p = 0.542). Therefore, the change of 16S rDNA in
lavage fluid across time points did not depend on the
genotype. Since the level of 16S rDNA was the highest
at 48 h, we also assessed the level of 16S rDNA in
blood at this time point (Fig. 6c). One-way ANOVA did
not indicate any difference between the WT PBS, the
WT E. coli, and the PKR E. coli experimental groups (F
= 0.547, df 2, 6, p = 0.605). Hence, such data also im-
plied that the bacterial infection did not spread into the
blood in both genotypes.
















4 h                        48 h                       120 h
Fig. 5 Relative mRNA expression profiles of IL-1β, TNF-α, IL-6, COX-2, and iNOS in the hippocampus. The deficiency of PKR had minimal effect on
inflammatory gene expression in the hippocampus after E. coli challenge. n = 7–8 per group at 4 h, n = 6–8 per group at 48 h, and n = 9–11 per
group at 120 h. *p < 0.05, **p < 0.01, ***p < 0.001
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PKR−/− mice exhibited a delayed induction of CRH in the
hypothalamus
It is known that systemic inflammation can trigger
hypothalamic CRH production and release [77] and that
endogenous CRH production mediates inflammation-
induced sickness [58, 78]. As PKR−/− mice demonstrated
several behavioral components of sickness that were not
observed in WT mice, we asked whether the CRH re-
sponse in PKR−/− mice would be different from that of
WT mice.
We found that PKR−/− mice developed a delayed
induction of CRH in the hypothalamus in response
to E. coli challenge (Fig. 7a). At 4 h post-injection, E.
coli significantly elevated CRH mRNA expression in WT
mice (p = 0.021, one-way ANOVA followed by Student-
Newman-Keuls post hoc comparison) but not in PKR−/−
mice (p = 0.519), and a significant difference (p = 0.01) was
also present between the E. coli-treated groups. In con-
trast, at 48 h post-injection, E. coli increased CRH ex-
pression only in PKR−/− mice (p = 0.003) but not in
WT mice (p = 0.851). Furthermore, the PKR−/− E. coli
group showed a significantly greater expression of CRH
(p = 0.003) than the WT E. coli group. Finally, no de-
tectable differences (p > 0.05) in CRH expression could
be observed at 120 h.
WT and PKR−/− mice showed similar changes in plasma
corticosterone levels
We then asked whether PKR−/− mice would display a
different profile for circulating corticosterone than WT
mice in response to E. coli. In rodents, basal plasma cor-
ticosterone levels follow a circadian pattern, with low
levels occurring during the morning and high levels in
the evening [79]. This circadian pattern can be observed
in WT and PKR−/− mice, with corticosterone levels being
higher (two-tailed tests, p < 0.01) in the late afternoon
(4 h/16:00) than in the morning (i.e., 48 h/12:00), i.e., 4 h
WT PBS (363 ± 42 ng/ml) v.s. 48 h WT PBS (128 ± 17 ng/
ml); 4 h PKR−/− PBS (402 ± 50 ng/ml) v.s. 48 h PKR−/−
PBS (113 ± 33 ng/ml). Baseline corticosteroid levels did
not differ between WT and PKR−/− mice (Fig. 7b). One-
way ANOVA followed by Student-Newman-Keuls post
hoc comparison showed no difference (p > 0.05) between
the WT PBS and PKR−/− PBS groups at either time point.
Immune challenge by E. coli led to similar changes in
plasma corticosterone levels in both genotypes. At 4 h, E.
coli increased corticosterone in both WT (WT PBS v.s.
WT E. coli; 363 ± 42 v.s. 545 ± 35 ng/ml; p = 0.023) and
PKR−/− mice (PKR−/− PBS v.s. PKR−/− E. coli; 402 ± 50
v.s. 622 ± 45 ng/ml; p = 0.004), but no difference was
found between the E. coli-challenged groups (WT E. coli
v.s. PKR−/− E. coli; p = 0.238). By 48 h, these increases
had dissipated (WT PBS v.s. WT E. coli: 128 ± 17 v.s.







Fig. 6 Loss of PKR did not enhance bacterial load. Lavage fluid
(injection site) and blood were sampled at the indicated time points.
In (a), serially diluted lavage samples from E. coli-challenged mice
were plated onto bacterial agar plates and incubated at 37 °C for 24
h. The numbers of colony-forming units (CFU) were similar between
WT and PKR−/− mice throughout the time points; n = 17–19 per
group. There was no CFU detected in the lavage fluid from the PBS-
injected mice. In (b), purified lavage fluid from E. coli-infected
animals were tested for their bacterial 16S rDNA levels, and
expressed as fold of baseline (i.e., PBS-injected animals). Similar levels
of 16S rDNA were observed between WT and PKR−/− animals;
n = 13–18 per group. In (c), anti-coagulated blood was collected
from mice at 48 h, purified, and assessed for 16S rDNA. No
significant increase of 16S rDNA could be found in the purified
blood samples of the two infected groups as compared to the WT
PBS group; n = 3 per group. We also could not culture any bacterial
colonies from blood sampled at this time point
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v.s. 121 ± 13 ng/ml), and no significant difference (p > 0.05)
could be detected between the experimental groups.
Discussion
Systemic inflammation triggers neuroimmune activation,
leading to sickness. In this study, we investigated the role
of PKR, a serine-threonine kinase that is activated by im-
mune challenge [45, 46] and regulates LPS-induced per-
ipheral inflammatory responses [48], on neuroimmune
responses and sickness following subcutaneous E. coli in-
fection. While genetic deficiency of PKR in mice did not
affect the core components of sickness (anorexia and
motor impairments), it led to several behavioral compo-
nents of sickness (decreased burrowing, exploratory defi-
cits, and social withdrawal) that were not observed in WT
mice (Fig. 1). Interestingly, such alteration in the behavioral
components was not due to exacerbated inflammation,
since the loss of PKR diminished peripheral inflammatory
changes (Figs. 2 and 3), and it had minimal effect on the
associated neuroimmune responses (Figs. 4 and 5). Like-
wise, bacterial titers (Fig. 6) and plasma corticosterone
profiles (Fig. 7b) did not differ between WT and PKR−/−
mice during the course of infection. Hence, the altered be-
havioral components in PKR−/− mice also did not result
from an impaired host defense to the E. coli infection or
from a dysregulated corticosterone response. However,
PKR−/− mice displayed a delayed induction of CRH after
E. coli challenge (Fig. 7), suggesting a postponed CRH re-
sponse in these mice that may possibly modulate sickness.
As expected, genetic deletion of PKR suppressed periph-
eral inflammatory responses to E. coli infection. Previous
studies have demonstrated that deficiency of PKR attenu-
ates plasma IL-6 and IL-12 increases after systemic LPS
challenge [48] and that PKR regulates inflammasome
activation [51] and TLR2/TLR4-dependent cytokine re-
lease [46] from cultured macrophages. Moreover, PKR
shows crosstalk with multiple inflammatory pathways
including NF-κB [47, 49], MAPK [48], IRF-1 [49], and
JNK signaling cascades [46, 47]. Our findings are there-
fore in agreement with these earlier reports. Since sys-
temic inflammatory mediators can communicate with


































4 h                                          48 h
(b)
Plasma
Fig. 7 PKR deficiency delayed hypothalamic CRH induction but did not affect the plasma corticosterone response. Hypothalamic CRH mRNA
expression (a) and plasma corticosterone levels (b) were assessed at indicated times after E. coli challenge. As shown in a, genetic deletion of PKR
abolished the elevation of CRH by E. coli at 4 h but triggered a delayed increase in the PKR−/− E. coli group at 48 h. n = 7–8 per group at 4 h,
n = 6–8 per group at 48 h, and n = 9–11 per group at 120 h. *p < 0.05, **p < 0.01. In b, E. coli caused similar increases of plasma corticosterone
at 4 h (16:00) in WT and PKR−/− mice. By 48 h (12:00), corticosterone levels in the E. coli-treated groups had returned to control levels. n = 7–10 per
group at 4 h, n = 5–7 per group at 48 h; *p < 0.05, **p < 0.01
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neuroimmune activation [3, 19], we asked whether PKR
deficiency could also suppress neuroimmune responses
after E. coli challenge.
To our surprise, WTand PKR−/− mice displayed mostly
similar neuroimmune changes. This is in contrast to sev-
eral earlier studies, which showed that pharmacological
inhibitors of PKR can abolish inflammatory responses in
glial cultures [50, 52, 80]. Until recently, it has also been
demonstrated that genetic deletion or pharmacological in-
hibition of PKR reduces neuroinflammation in animal
models of viral encephalomyelitis [53] and excitotoxic
injury [54]. It should be noted that in these studies, in-
flammatory changes were initiated directly in glial cultures
or by direct brain insults, whereas in our scenario neu-
roimmune activation occurred subsequently to subcutane-
ous inflammation caused by E. coli. This notable deviation
suggests that PKR in the brain and PKR at peripheral tis-
sues may act differentially to affect neuroimmune re-
sponses under different causes. It is known that systemic
immune challenge can promote the recruitment of neu-
trophils [81–84] and monocytes [85, 86] into the brain
and that infiltrating leukocytes can influence inflammatory
changes in the brain [84, 87, 88] and even LPS-induced
depression-like behavior [84]. For instance, a single injec-
tion of LPS dose dependently elevates the number of infil-
trating neutrophils into the facial nucleus within 48 h, a
phenomenon that can persist up to at least 96 h [83].
Given that E. coli challenge led to a sustained infection
along with increased inflammatory factors up to 120 h, it
is expected to have a similar effect as a high dose of LPS
to cause considerable leukocyte infiltration into the brain.
One possibility could be that PKR may modulate this
leukocyte infiltration process. Should this be the case,
even if deficiency of PKR can downregulate the neuroim-
mune changes mediated by glial cells, this effect may be
masked by the inflammatory responses elicited by the in-
filtrating leukocytes. Indeed, PKR−/− mice display en-
hanced T cell recruitment into the brain during viral
encephalomyelitis [53], suggesting that PKR may also
regulate the entry of other leukocyte cell types into the
brain. Further investigation along this direction may pro-
vide clues as to how PKR controls neuroimmune activa-
tion during systemic immune insults.
Irrespective to the cause for the similar neuroimmune
responses, PKR−/− mice did show decreased peripheral
inflammatory changes. This finding led us to predict that
sickness might also be diminished in PKR−/− mice, since
sickness can be ameliorated by blockade of peripheral
cytokine synthesis or their effects [27, 29, 32, 89], or by
genetic deletion of NF-κB [90]. Therefore, we monitored
both core (anorexia, motor impairments) and behav-
ioral (burrowing and exploratory deficits, social with-
drawal) components of sickness [1, 5, 19, 71, 91] in WT
and PKR−/− mice after E. coli challenge. Previous
literature has shown that these two types of sickness com-
ponents can be temporally [11, 92–94] and pharmacologic-
ally [27, 29, 93, 94] dissociated, indicating that the two
types of sickness components involve different regulatory
mechanisms. For example, LPS-induced deficit in burrow-
ing can persist up to 24 h, when the decrease in locomotor
activity is no longer observed [11]. On the other hand,
while administration of cyclooxygenase (COX) inhibitors
can ameliorate both core (hypothermia, impaired loco-
motor activity) and behavioral (decreased burrowing)
components of sickness following LPS challenge, block-
ade of peripheral cytokine synthesis by dexamethasone
or dexamethasone-21-phosphate only attenuates LPS-
mediated hypothermia [27, 29]. Here, our data demon-
strate a rather unexpected finding. Knockout of PKR in
mice did not elicit any reduction in sickness responses.
Instead, the core components of sickness were similar
between both strains of mice, and the behavioral compo-
nents of sickness were only observable in PKR−/− mice.
Of particular interest is that PKR−/− mice showed de-
creased activities in the open field test, object investigation
test, and social interaction test even at 120 h, although
these changes were absent in WT mice at the same time
point. It should be noted that these exploratory and social
deficits observed only in PKR−/− mice were not simply
because of a general decrease in motor activity, because
rotarod performance had been restored to the control
level by 96 h. Thus, this is an indication that deficiency of
PKR primarily affected the behavioral components of sick-
ness but not the core components. We did not perform
these tasks at an earlier time because we had specifically
wanted to distinguish the roles of PKR on the core and be-
havioral components of sickness. Moreover, both strains
of mice displayed decreased rotarod performance at 24 h,
indicating that the use of these behavioral assays at or be-
fore this time would not allow us to separate the effects of
the core and behavioral components of sickness. Given
that LPS is well reported to abolish exploratory activity
[10, 95] and induce social withdrawal [96–98] in WT ani-
mals within several hours after systemic administration, it
is likely that E. coli can also lead to these deficits in the
two strains of mice under this time frame.
Interestingly, we did not detect any change in the bur-
rowing activity of WT mice after E. coli. This would
seem contradictory to earlier reports which demon-
strated that LPS acutely decreases burrowing in WT ani-
mals [11, 27, 28]. However, it should be emphasized that
these studies have used food pellets as the burrowing sub-
strate, whereas here we used bedding material (wood
chips) to avoid interference effects on the measurements
of food consumption. It has been documented that differ-
ent types of burrowing substrates can greatly influence the
burrowing activity measured in rodents [99, 100]. C57BL/
6 mice typically burrow a greater proportion of the
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burrowing substrate when the burrowing tube is filled
with bedding material than when it is filled with food pel-
lets. For example, Kir6.2 knockout mice display severely
impaired burrowing as compared to WT mice when food
pellets are used, but this difference becomes less obvious
when the burrowing substrate is replaced with bedding
material [99]. Based on these studies, it could be de-
duced that bedding material is more preferred than
food pellets as a burrowing substrate by C57BL/6 mice,
such that it will be harder to detect phenotypic differ-
ences with bedding material than with food pellets. Per-
haps WT mice would have displayed burrowing deficits
after E. coli challenge if the burrowing tubes had been
filled with food pellets.
Next, we asked whether the alterations in the behav-
ioral components of sickness of PKR−/− mice would be
correlated with exaggerated bacterial load. It has been
well reported that loss of PKR can often enhance viral
replication [41, 44, 101, 102]. Another study has shown
that PKR is involved in resistance to Toxoplasma gon-
dii [45]. To our knowledge, however, the effect of PKR in
bacterial infection has been little investigated [51]. Here,
we made use of two different methods, i.e., microbio-
logical plate count and quantification of 16S rDNA by
real-time PCR, and show that bacterial titers were similar
between the two strains of mice throughout the course
of infection. These results imply that altered sickness
in PKR−/− mice was not due to an impaired host
defense to E. coli. In fact, even if PKR deficiency does
affect E. coli infection, it would likely suppress it. This
point is supported by another study by Lu et al., in
which PKR−/− mice had reduced bacterial titers fol-
lowing E. coli-induced peritonitis [51].
We then investigated if PKR could modulate the CRH
response to E. coli challenge. Previous studies have indi-
cated that systemic inflammation leads to CRH induc-
tion and release from paraventricular nucleus (PVN)
neurons of the hypothalamus [56, 77]. Furthermore, ad-
ministration of CRH into rodents acutely reduces ex-
ploratory activities to novel environments [103] and to
novel individuals [104]. These behaviors are quite similar
to what was observed in PKR−/− mice at 120 h after E.
coli challenge. Our data indicate that while E. coli upreg-
ulated CRH expression at 4 h in the hypothalamus of
WT mice, such increase was not found in PKR−/− mice.
This finding is not surprising, given that systemic in-
flammation induces CRH, and PKR−/− mice showed re-
duced peripheral inflammation. However, at 48 h after E.
coli infection, there was a significant elevation of CRH
in PKR−/− mice but not in WT mice. Hence, it appears
that PKR deficiency can delay CRH induction in re-
sponse to E. coli. It is also possible that knockout of
PKR may extend the CRH response period, although this
requires validation in a more detailed temporal manner.
The altered CRH response in PKR−/− mice suggest that
these CRH-mediated effects may also be postponed or
extended, which can possibly alter the behavioral com-
ponents of sickness in PKR−/− mice. Indeed, chronic ad-
ministration of CRH into the brain can delay behavioral
inhibition induced by LPS [105], thus providing indirect
evidence to support this possibility. Future studies
should address the role of PKR on the CRH response
along with its implication on sickness.
We have known that CRH participates in the HPA axis
to stimulate adrenocorticotrophic hormone (ACTH) syn-
thesis and release from the anterior pituitary [77]. ACTH
in turn acts on the adrenal cortex, inducing corticosterone
production and secretion. Upon systemic LPS challenge,
corticosterone is increased in the circulation, and several
reports have also demonstrated that endogenous cortico-
sterone can suppress peripheral inflammation and sick-
ness [55, 59, 60]. As PKR−/− mice exhibited a delayed
CRH induction, we questioned whether this would result
in differential responses of corticosterone to E. coli. Sur-
prisingly, there was no significant change in the levels of
plasma corticosterone between WT and PKR−/− mice.
Plasma corticosterone levels were elevated by E. coli to the
same extent in WT and PKR−/− mice at 4 h, and by 48 h
these increases had disappeared in the E. coli-challenged
groups. These results suggest that the altered sickness be-
haviors in PKR−/− mice were not due to a dysregulated
corticosterone response. Furthermore, corticosterone pro-
files in the two strains of mice did not follow the same
trend as that of hypothalamic CRH. While CRH induction
was blunted at 4 h in PKR−/− mice relative to WT mice,
corticosterone was similarly increased in both genotypes.
At 48 h, CRH was induced in PKR−/− mice, but plasma
corticosterone was not upregulated. Such a discrepancy
between the CRH and corticosterone profiles might be
due to the following possibilities. Firstly, CRH production
is not limited to the hypothalamus. Extra-hypothalamic
sources of CRH [106–109] may likely serve as alternative
source(s) of CRH in PKR−/− mice, such that hypothal-
amic CRH production would not be required at 4 h in
these mice. Of particular relevance is that CRH is highly
expressed at peripheral inflammatory tissues to regulate
local immune responses [109]. If deficiency of PKR can
hyper-induce CRH at inflammatory sites during the E. coli
infection, such CRH may potentially spill over into the
bloodstream and upregulate corticosterone. Secondly,
while corticosterone production is regulated by CRH, it
can also be triggered by vasopressin through the type 1b
vasopressin receptor in the anterior pituitary [110]. Per-
haps PKR can act at the level of vasopressin system,
thereby exerting its control over the level of cortico-
sterone. Thirdly, elevated corticosterone has been shown
to decrease CRH-R1 mRNA and CRH binding [111].
Since corticosterone was increased before 48 h in PKR−/−
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mice, this could explain why these mice were unable to
mount another wave of corticosterone response even
though CRH was induced at 48 h.
It is noteworthy that despite the dissociation between
hypothalamic CRH and circulating corticosterone profiles
in PKR−/− mice, the possible involvement of the delayed
CRH response in altering sickness behaviors should not
be simply ruled out. CRH participates in the HPA axis,
but CRH effects are not entirely mediated by ACTH or
corticosterone. CRH is a neurotransmitter and it can bind
to widely distributed receptors CRH-R1 and CRH-R2 in
the brain [112]. Indeed, many of the brain regions that ex-
press CRH receptors, including the hippocampus, amyg-
dala, hypothalamus, midbrain, and cerebral cortex, are not
responsible for ACTH production. Instead, direct manipu-
lation of CRH signaling in these brain structures often
results in behavioral changes that are also observed in
sickness. For instance, specific deletion of CRH-R1 in
midbrain dopaminergic neurons causes anxiety and in-
hibits dopamine release in the prefrontal cortex [113]. In
the same study, it was shown that deletion of CRH-R1 in
forebrain glutamatergic neurons decreases anxiety and
neurotransmission in the hippocampus and amygdala.
Moreover, the direct infusion of CRH into the hippo-
campus enhances long-term potentiation and improves
context-dependent fear conditioning [114]. Interestingly,
many of the brain structures that express CRH receptors
are also involved in sickness [20], thus supporting for a
role of CRH in modulating sickness. A delay in the CRH
response in PKR−/− mice suggests that endogenous CRH
signaling at an early time after the E. coli infection is re-
quired for normal sickness development.
In addition to the delayed CRH response, other pa-
rameters can be studied in future to better understand
sickness in PKR−/− mice. For example, many inflamma-
tory mediators such as NF-κB [90], microsomal PGE
synthase-1 (mPGES-1) [115, 116], and transcription fac-
tor nuclear factor interleukin 6 (NF-IL-6) [117] have
been demonstrated to control sickness and are potential
candidates to alter sickness behaviors in PKR−/− mice.
In particular, PKR modulates NF-κB activation [47, 49],
and genetic deletion of NF-κB abolishes sickness in-
duced by LPS and unmethylated cytosine-phosphate-
guanosine motifs (CpG-DNA) [90]. We have focused on
quantifying inflammatory gene expression in the brain.
This was because inflammatory gene expression serves
as a good indicator of local neuroimmune activation and
that it could enable us to assess multiple inflammatory
markers with a limited amount of sample material. Sub-
sequent investigation of neuroimmune markers at pro-
tein level would be important to further characterize
neuroimmune responses and their relationships to sick-
ness. For example, iNOS mRNA expression was in-
creased to a slightly lesser degree in the PKR−/− E. coli
group than in the WT E. coli group at 48 h in the hypo-
thalamus. It is known that systemic LPS upregulates
iNOS mRNA expression in the hypothalamus [118] and
that pharmacological inhibition of iNOS attenuates LPS-
induced sickness responses [34]. Our mRNA results raise
questions as to whether E. coli could indeed upregulate
iNOS protein in the hypothalamus and if PKR could
modulate iNOS protein production that can potentially
affect sickness. Finally, systemic inflammation can activate
the indoleamine-2,3-dioxygenase (IDO) pathway, leading
to the catabolism of tryptophan (TRP) to kynurenine
(KYN) in the brain and blood [94]. In the same study,
pharmacological inhibition of the IDO pathway was
shown to alleviate LPS-induced depressive-like behav-
ior. In another study, genetic deletion or pharmaco-
logical inhibition of IDO ameliorates depressive-like
behaviors triggered by an intracerebroventricular injec-
tion of LPS [119]. Since PKR−/− mice developed ex-
ploratory activity and social interaction deficits up to
120 h, a dysregulation of the IDO pathway is another
reasonable possibility that may account for these al-
tered sickness behaviors.
A major limitation of our study is that we have used a
general knockout approach to model the effect of PKR
on neuroimmune activation and sickness. Since PKR is
ubiquitously expressed, it is difficult to pinpoint tissue-
specific effects of PKR during systemic inflammation.
For instance, we discussed the possibility that PKR dele-
tion at peripheral tissues may enhance leukocyte recruit-
ment into the brain, thereby masking the reduction of
neuroimmune responses in glial cells. This issue can be
more easily studied if PKR conditional knockout mice
were used. Perhaps, it will be beneficial to generate dif-
ferent lines of mice having specific knockout of PKR in
target tissues, so as to better characterize the role of
PKR during systemic inflammation.
We believe that our findings have important implica-
tions. Firstly, we identify a novel role of PKR in regulat-
ing sickness, particularly the behavioral components of
sickness. As an over-exaggeration of sickness may pre-
cipitate depression [5, 19] and/or delirium [3, 6], gaining
a better understanding on sickness regulation can shed
light on how to fine tune sickness responses. Ideally, one
would want to preserve the physiological functions of
sickness without causing severe side effects. Secondly,
reports in the recent decade have demonstrated that
PKR inhibition can be neuroprotective [119–122] and
improve cognition [123]. Here, we provide additional in-
formation on PKR deficiency during systemic inflamma-
tion, and this can complement the earlier studies. While
we did show that loss of PKR altered the behavioral
components of sickness, we should not simply neglect
the desirable effects of PKR inhibition in neurodegenera-
tive processes and memory. Instead, the efficacy of PKR
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pharmacological inhibitors should be justified after con-
sidering both positive and negative effects and taking
into account of the patient’s disease status.
Conclusions
Systemic inflammation leads to neuroimmune activation
and sickness. While these phenomena have been well
studied, the mechanisms involved in their regulation re-
main unclear. Our study indicates that genetic deletion
of PKR led to alteration in the behavioral components of
sickness and this was unlikely to be caused by exagger-
ated neuroimmune responses, increased bacterial load,
or a dysregulated corticosterone response. Instead, PKR
deficiency delayed CRH induction after immune chal-
lenge by E. coli. Future investigations can address the
role of PKR in the CRH response, together with its rela-
tion to sickness.
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